Merz Aesthetics today announced that the company has received two distinctions from Great Place to Work® and Healthiest Employers®.

Merz Aesthetics today confirmed its commitment as a global leader in medical aesthetics at the 19th Aesthetic & Anti-Aging Medicine World Congress (AMWC), with the presentation of data from its medical aesthetics portfolio and a clear focus on addressing the aesthetic needs of a diverse society.

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today the launch of the Merz Aesthetics Medical Forum, a unique online medical aesthetics education platform for health care professionals around the world.

Merz Aesthetics announced the presentation of data from its extensive medical aesthetics portfolio at The Aesthetic Meeting 2021.

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today the United States launch of BELOTERO BALANCE (+), the lidocaine formulation of BELOTERO BALANCE.

Eight accepted abstract presentations provide key updates on Xeomin® (incobotulinumtoxinA)

Committed to innovative customer solutions and meeting patient demand for full-spectrum of medical aesthetic treatment.

Merz Aesthetics, a global leader in medical aesthetics, today announced the presentation of data from its medical aesthetics portfolio at the 18th edition of the Aesthetic & Anti-Aging Medicine World Congress.

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, today announced the presentation of data from its medical aesthetics portfolio.

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today a partnership with Oscar and Emmy-award-winning actor, author and entrepreneur, Gwyneth Paltrow, for the launch of the company’s first global campaign for Xeomin® (incobotulinumtoxinA).

Merz Aesthetics is pleased to announce today the launch of the “confidence to be” branding platform following the conclusion of the company’s reorganization into three independently operating businesses.

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, today announced the appointment of Karl Kokrhoun as Chief Financial Officer, effective May 4, 2020.

Merz Aesthetics, the largest dedicated medical aesthetics business globally, today announced the appointment of Samantha Kerr, Ph.D., as Chief Scientific Officer, effective March 16, 2020.

Merz, a global leader in the field of aesthetics and neurotoxins, today announced plans to reorganize into three independently operating businesses: medical aesthetics, therapeutics and consumer care.

Merz, a global leader in medical aesthetics, today announced the presentation of data from its aesthetics products, including Xeomin® (incobotulinumtoxinA), Ultherapy®, and Radiesse®, at the American Society of Dermatologic Surgery 2019 Annual Meeting which is taking place in Chicago from October 24 to 27.

Merz announced today the U.S. Food and Drug Administration (FDA) has cleared Cellfina’s® new indication statement that shows the benefits of Cellfina last for five years, an increase from the previous three-year indication.

Today Merz announced Bob Rhatigan, CEO of Merz Americas, has been named one of the top 100 most inspiring and influential life sciences leaders by PharmaVOICE magazine, a premiere health care trade publication.

Merz Americas announced three updates for NEOCUTIS including the launch of NEOCUTIS Aftercare, a post-treatment soothing cream that can enhance post-procedure outcomes; new packaging for best-selling products Lumière, Lumière Riche and Bio Serum; and the recognition from InStyle for the 20th time as a Best Beauty Buy award winner.

Merz Named “Top Aesthetics Company” by Aesthetic Everything® for Third Year in a Row... Merz Americas CEO Bob Rhatigan named “Top Aesthetics CEO” for the third year in a row.... Key products XEOMIN®(incobotulinumtoxinA) and Ultherapy® recognized with best-in-class awards

Accepted abstracts provide key updates on aesthetics products, including XEOMIN® (incobotulinumtoxinA), ULTHERAPY®, RADIESSE® and CELLFINA®.

Merz Americas today announced the presentation of data, including one oral presentation, from studies of its aesthetics products, including Xeomin^® (incobotulinumtoxinA), Ultherapy^®, Radiesse^® and the Cellfina^® System, at the American Academy of Dermatology (AAD) annual meeting, March 1-5, in Washington, DC.

Merz Americas is partnering with supermodel, actress and entrepreneur, Christie Brinkley, to launch a new campaign, “Milestones of Me,” which encourages women to celebrate the moments, big or small, that have made them who they are today. The campaign kicks off in honor of Christie’s 65th birthday, and inspires women to not shy away from wanting to look and feel their best as they celebrate new milestones. At nearly 65, one of the ways Christie continues to look and feel great is with Ultherapy^®

Merz Americas announced today the launch of a new advertising campaign for XEOMIN® (incobotulinumtoxinA) called “Later Haters,” which calls for women to “X out” judgment, stop apologizing for caring about how they look and put an end to feeling guilty about their self-care routines. XEOMIN is the latest botulinum toxin type A approved by the U.S. Food and Drug Administration (FDA) to temporarily improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults.

For the second year in a row, Merz has been recognized as the “Top Aesthetics Company” by Aesthetic Everything® and Bob Rhatigan has been named the “Top Aesthetics CEO.” As part of the annual Aesthetic and Cosmetic Medicine Awards, Merz executives and products were also recognized with 14 additional award wins – 16 total wins overall.

Merz, a global leader in medical aesthetics, presented five-year follow-up data on Cellfina® System, which showed that a single treatment improved the appearance of cellulite on the thighs and buttocks for five years, building upon a previous study, which showed results lasting at least three years

Merz today announced Kristina Yu-Isenberg, Ph.D., M.P.H, R.Ph., has been named Vice President of Medical Affairs North America, effective immediately. Dr. Yu-Isenberg oversees medical affairs in North America and is located in the Merz North America headquarters in Raleigh, North Carolina.

Merz, a global leader in medical aesthetics and neurotoxins, today announced the appointment of Bob Rhatigan as Chief Executive Officer – Americas. Expanding on his leadership of Merz’s North American business, Mr. Rhatigan will now assume responsibility for Latin America as well and will oversee the overall commercial strategy for the newly-created Americas Region. In addition, Frank Brandt-Pollmann has been promoted to Area Vice President – Latin America...

Merz North America today announced the appointment of Alana Sine to Chief Financial Officer (CFO), Merz North America. Sine has served as interim CFO since March 2018.

Merz announced today that Ultherapy®, Radiesse® and Cellfina® have been named the best “In-Office Treatments” by NewBeauty Magazine. In addition, Cellfina® was recognized as the “Best Non-Surgical Body Shaping Device” by THE European Aesthetic Guide. Neocutis® Lumière® and Lumière® Riche were named “Best Beauty Buys” by InStyle Magazine...

Merz North America today announced the results of a survey, conducted by Wakefield Research, to better understand public perceptions of tattoo removal. The survey results found that more than four in five adults with (86%) and without (82%) tattoos have misconceptions about tattoo removal...

Merz North America announced today that Merz aesthetics products including Xeomin®, Cellfina®, Radiesse®, Ultherapy® and DeScribe® PFD Patch will be featured in oral and online ePoster presentations at the American Academy of Dermatology (AAD) annual meeting in San Diego, CA, taking place February 16-20, 2018...

Merz today announced that Terri L. Phillips, M.D., F.A.A.P., has been named Vice President and Head of Global Medical Affairs, effective January 2, 2018. Dr. Phillips will oversee the global medical affairs team and will be located in the Merz North America headquarters in Raleigh, N.C...

Merz North America announced today the DESCRIBE® PFD Patch has been cleared by the Food and Drug Administration (FDA) for all commonly used lasers for tattoo removal.

Merz announced today Ultherapy® has been named the "Best Skin Tightening Device" by THE Aesthetic Guide, a leading aesthetic industry publication. Ultherapy® is the only FDA- cleared, non-invasive procedure that lifts and tightens the neck, chin and brow, and improves lines and wrinkles on the chest.

Merz North America, Inc. announced today that Merz has been recognized by Aesthetic Everything® as the Top Aesthetics Company and the winner of four other 2017 Diamond Crystal Awards, including the recognition of Cellfina® as the Top Minimally Invasive Procedure and Ultherapy® as a Top Non-Surgical Procedure in the industry.

Merz Aesthetics, a division of Merz North America, announced today that NEOCUTIS® Lumière was named an InStyle 2017 "Best Beauty Buy" award winner for "Best Eye Cream."

Merz Aesthetics, a division of Merz North America announces the U.S. launch of Mederma® Quick Dry Oil, a unique, fast-absorbing multipurpose oil formulated without artificial dyes, colors, perfumes, parabens or mineral oils that works to help diminish the appearance of scars, stretch marks, uneven skin tone and dry skin, and Mederma® Spezial, a unique collection of cream mousses and dietary supplements formulated to promote healthy skin, hair and nails.

Merz Pharma, a global leader in aesthetics and neurotoxins, today announced the appointment of Bob Rhatigan as President and Chief Executive Officer (CEO) of Merz North America and Patrick Urban as Chief Commercial Officer

Merz Aesthetics, a division of Merz North America, announced today that Ultherapy® and the Cellfina® System have been recognized by NewBeauty readers and editors in their 2017 Beauty Choice Awards as best-in-class.

Merz Aesthetics, a division of Merz North America (U.S. affiliate of Merz Pharma Group) announced the 10-year anniversary of the launch of their flagship brand, Radiesse . Radiesse is a volumizing filler used in more than 60 countries, and is unique in its ability to provide instant lift and stimulate the natural production of collagen with just one injection. More than 6 million syringes have been purchased by professionals worldwide over the past ten years.

Merz Aesthetics, a division of Merz North America (U.S. affiliate of the global Merz Pharma Group), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Cellfina™ System for the long-term improvement in the appearance of cellulite on the buttocks and thighs of adult females with no loss of benefit for up to 3 years.

Merz Aesthetics, a division of Merz North America (US affiliate of the global Merz Pharma Group), announced today that NEOCUTIS MICRO•NIGHT® RICHE Rejuvenating Balm is an O, The Oprah Magazine Fall Beauty 2016 “O-Ward” winner for being a top performer in the Night Treatment category for sensitive skin.

Merz North America announced today it has expanded its aesthetic portfolio through the acquisition of ON Light Sciences, Inc.

Merz Aesthetics, a division of Merz North America (US affiliate of the global Merz Pharma Group), announced today that the Cellfina™ System has received the 2016 Good Housekeeping Best of Beauty Awards in the Body Solution category. Cellfina™ is the only FDA-cleared minimally invasive procedure clinically proven to improve the appearance of cellulite in the buttocks and thighs of adult females, for results that last at least two years, the longest duration cleared by the FDA. Winners are featured in the May 2016 issue of Good Housekeeping Magazine.

Merz Aesthetics, a division of Merz North America (US affiliate of the global Merz Pharma Group), announced today that NEOCUTIS® Lumière and Lumière Riche were named InStyle 2016 “Best Beauty Buys” award winners for Best Eye Treatment and Best Eye Treatment for Dry Skin, respectively.

Merz Aesthetics, a division of Merz North America (US affiliate of the global Merz Pharma Group) announced today that its Cellfina™ System will launch nationwide at the Annual Meeting for the American Society for Aesthetic Plastic Surgery in Las Vegas, NV. Cellfina is the only FDA-­cleared, minimally invasive procedure clinically proven to improve the appearance of cellulite for results that last at least two years – the longest duration cleared by the FDA.

Merz Aesthetics, a division of Merz North America (US affiliate of the global Merz Pharma Group) announced today that Ultherapy® has been named “Best Nonsurgical Skin Tightener” in the 2016 Beauty Choice Awards.

Merz Aesthetics Skincare, a division of Merz North America (U.S. affiliate of Merz Pharma Group) today announced the launch of its newest skincare product, MICRO•FIRM™ NECK & DÉCOLLETÉ Rejuvenating Complex by NEOCUTIS®. This advancement in anti-aging skincare was developed to help revitalize skin and improve the appearance of aging on the neck and décolleté. Formulated with Micro Protein Complex (MPC™), this unique peptide blend is the first anti-aging technology to help rejuvenate skin’s elasticity.

Merz Aesthetics, a division of Merz North America (US affiliate of the global Merz Pharma Group) announced today that it will be presenting 13 posters at the annual American Academy of Dermatology Meeting this weekend in Washington D.C.